Skip to main content

Day: January 12, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Warsaw, Poland

SAN DIEGO, Jan. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has opened a new office and warehouse in Warsaw, Poland. The new 7,771 square foot warehouse is strategically positioned near the Warsaw airport and city center, making it easily accessible for employees and visitors. The facility allows Kannaway® to use the Polish Post, DPD, and UPS to ship its high-quality cannabidiol (CBD) products to more than 30 countries in Europe. The warehouse operations follow Hazard Analysis Critical Control Points (HACCP) and Good Hygiene Practice (GHP). “Our company...

Continue reading

INE Acquires CloudSkills.io to Enhance Real-World Cloud Training

INE to Integrate New Content, Custom Bootcamps Into Award-Winning Cloud Platform Cary, NC, Jan. 12, 2022 (GLOBE NEWSWIRE) — INE, the global leader in Information Technology training, announced today it has acquired CloudSkills.io, an immersive cloud consulting and training firm, widely praised by users for its highly skilled instructors, practical projects, and deep learning across the cloud sector. The addition of CloudSkills.io will augment the hands-on, practical training INE is known for with more than 200 hours of cloud content. This joining of forces will also help supercharge the cloud training industry at a time when businesses are grappling with a growing dependence on cloud and a massive skills gap. INE recently revamped its training platform to include more than 2,200 cloud-based, hands-on labs in a move that is already...

Continue reading

Wellframe Achieves Momentous Growth in 2021, Accelerating Its Ability to Modernize the Member Experience

The Boston-based company concludes the year with a 100% year over year revenue growth that further accelerates its commitment to fixing American health insurance BOSTON, Jan. 12, 2022 (GLOBE NEWSWIRE) — Wellframe, the provider of the market-leading digital health management platform, closes 2021 with momentous growth. From notable business deals to industry-wide acknowledgements, Wellframe established itself as a leader in the space with 40% year over year growth in members onboarded to its platform and an acquisition by HealthEdge Software, provider of the industry’s leading next-gen integrated solution suite for health plans. The closed acquisition will further advance Wellframe’s footprint in the digital health transformation movement. “We’re proud of what we accomplished in 2021, having realized meaningful growth in members,...

Continue reading

Intuitive Announces Preliminary Fourth Quarter and Full Year 2021 Results

SUNNYVALE, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) — Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2021 financial results ahead of its participation at the 40th Annual J.P. Morgan Healthcare Conference occurring January 10-13, 2022. Financial and Operational HighlightsFourth quarter 2021 worldwide da Vinci procedures grew approximately 19% compared with the fourth quarter of 2020. The fourth quarter of 2020 reflected significant disruption caused by the COVID-19 pandemic, and the fourth quarter of 2021 reflected a COVID-19 resurgence later in the quarter, which also impacted our procedures. The compound annual growth rate between the fourth quarter of 2019 and...

Continue reading

Calibre Mining Completes Acquisition of Fiore Gold

VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) and Fiore Gold Ltd. (“Fiore”) (TSXV: F; OTCQB: FIOGF) are pleased to announce the successful completion of the previously announced transaction pursuant to which, among other things, Calibre acquired all of the issued and outstanding common shares of Fiore (the “Fiore Shares”) pursuant to a court-approved plan of arrangement (the “Arrangement”). Pursuant to the Arrangement, former Fiore shareholders received 0.994 of a Calibre common share (each whole share, a “Calibre Share”) and a cash payment of C$0.10 in exchange for each Fiore Share held. As a result of the Arrangement, Calibre issued an aggregate of 101,321,923 Calibre Shares and made an aggregate cash payment of approximately C$10.2 million....

Continue reading

Otonomo Appoints Fred Kohout as Chief Marketing Officer

Seasoned executive tapped to build and scale Otonomo’s Go-To-Market Strategy HERZLIYA, Israel and SAN JOSE, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) — Otonomo Technologies Ltd. (Otonomo), (Nasdaq: OTMO), a leading mobility intelligence provider, today announced the appointment of Fred Kohout as Chief Marketing Officer (CMO). Bringing more than three decades of sales and marketing experience to Otonomo, Kohout will be charged with scaling Otonomo’s brand to demand engine to capitalize on the immense market opportunity represented by connected vehicle data and mobility intelligence. Mr. Kohout joins a growing executive team at Otonomo, including recently appointed leaders Doron Simon, Executive Vice President of Corporate Development and Strategy, Anders Truelsen, Chief Revenue Officer, and Amit Hammer, EVP Operations. Kohout, Simon,...

Continue reading

Jennifer Aniston partners with Idorsia U.S. to launch ‘Seize the Night & Day’ campaign inspiring Americans to understand their relationship with sleep

Jennifer Aniston partners with Idorsia U.S. to launch ‘Seize the Night & Day’ campaign inspiring Americans to understand their relationship with sleepJennifer reveals for the first time her sleep story spanning many years of challenges and how she has learned to make sleep a priority to have both better nights and days National education campaign provides a beacon of hope by shining a light on the approximately 25 million adults in the US living with insomnia Campaign provides educational resources to help people and healthcare providers understand insomnia’s dual impact that affects both nights and daysAllschwil, Switzerland & Radnor, PA, US – January 12, 2022Idorsia Ltd (SIX: IDIA) and Idorsia Pharmaceuticals, US Inc. today announced its partnership with award-winning actor and director/producer Jennifer Aniston to launch...

Continue reading

Sharps Compliance Announces Second Quarter Fiscal 2022 Conference Call and Webcast

HOUSTON, Jan. 12, 2022 (GLOBE NEWSWIRE) — Sharps Compliance Corp. (NASDAQ: SMED) announced today that it will release its second quarter 2022 results for the period ended December 31, 2021, before the opening of the financial markets on Wednesday, January 26, 2022. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company’s financial results, key market initiatives and business strategy. The Sharps Compliance conference call can be accessed by domestic callers by dialing (888) 506-0062. International callers may access the call by dialing (973) 528-0011. Callers should use conference entry code 618730. The webcast can be monitored at www.sharpsinc.com. A telephonic replay will be available through February 25, 2022. To listen to the replay, domestic callers should dial (877) 481-4010...

Continue reading

Dave Kelly Joins Onex as Head of Gluskin Sheff

All amounts in U.S. dollars unless otherwise stated  TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced the appointment of Dave Kelly as Head of Gluskin Sheff + Associates Inc. (“Gluskin Sheff”), Onex’ exclusive wealth management platform and one of Canada’s pre-eminent wealth management firms. Mr. Kelly brings extensive experience in the Canadian private wealth industry and his leadership will add valuable operational expertise as Onex continues to grow and expand its platform. “Gluskin Sheff is competitively differentiated in the market, being one of the only firms to provide clients with access to alternative investments and wealth planning solutions,” said Bobby Le Blanc, President of Onex. “Dave’s experience building strong operational functions to support high-quality, growing...

Continue reading

Tenax Therapeutics Granted U.S. Patent for the Subcutaneous Use of Levosimendan (TNX-102)

Provides Broad Coverage for Use of TNX-102 for the Treatment of Human Subjects with Any Health Condition Patent Term to 2039, Exclusive of Any Possible Extensions   MORRISVILLE, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for the company’s subcutaneous formulation of levosimendan, TNX-102, which is currently being developed for the treatment of pulmonary hypertension associated with left heart failure (PH-HFpEF). On January 4, 2022, Tenax Therapeutics was issued US Pat. No. 11,213,524, entitled PHARMACEUTICAL COMPOSITIONS...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.